Cookies help us deliver our services. By using our services, you agree to our use of cookies. More information

Difference between revisions of "NextGen-O2k Exploitation"

From Bioblast
Line 22: Line 22:
:::: '''2020-10-03:''' [[Gnaiger Erich|Erich Gnaiger]] travels to Fukuoka to attend J-Mit and ASMRM 2019 and meet our distributor [[ JP Tokyo Berthold|Berthold Japan K.K.]]
:::: '''2020-10-03:''' [[Gnaiger Erich|Erich Gnaiger]] travels to Fukuoka to attend J-Mit and ASMRM 2019 and meet our distributor [[ JP Tokyo Berthold|Berthold Japan K.K.]]
:::: '''2019-07-01:''' The first Distributor Meeting took place, see more: [[OroDM01 Innsbruck AT| Oroboros Distributor Meeting]]
:::: '''2019-07-01:''' The first Distributor Meeting took place, see more: [[OroDM01 Innsbruck AT| Oroboros Distributor Meeting]]
<br/>
<gallery mode=default perrow=4 widths="350px" heights="300px">
File:ASMRM2021.JPG
File:JP Onsite.jpg
File:ORODM1A.jpg
|-
</gallery>




== Links and references ==
== Links and references ==

Revision as of 17:23, 9 March 2020

Template:MitoFit highlights page name

NextGen-O2k

The revolutionary all-in-one instrument to conquer mitochondrial disease.



WP4: Exploitation



Abstract

Preparation for a successful market launch of the NextGen-O2k.


Progress and next steps

2020-02-04: Our Mitochondrial Wizard Luiza Daltro Cardoso, PhD went to Japan to meet our distributor and teach him high-resolution respirometry combined with H2O2, mt-membrane potential and ATP production measurements: Distributor engagement Tokyo JP
2020-10-03: Erich Gnaiger travels to Fukuoka to attend J-Mit and ASMRM 2019 and meet our distributor Berthold Japan K.K.
2019-07-01: The first Distributor Meeting took place, see more: Oroboros Distributor Meeting




Links and references